OR WAIT null SECS
The FDA has issued a Class I recall for some of Fresenius Medical Care's hemodialysis machines due to potential exposure to toxic compounds, affecting eight specific models from the 2008 Series.
The US Food and Drug Administration has announced a Class I recall of some hemodialysis machines from Fresenius Medical Care for potential exposure to toxic compounds.
The recall comes after the FDA announced it would be evaluating hemodialysis machines from Fresenius Medical Care for potential risk of exposure to toxic compounds in May 2022 and includes 8 specific models of 2008 Series Hemodialysis Machines. In their announcement, the FDA underlined the Class I recall was considered a correction and not a product removal.1
According to the FDA, the distribution dates of the affected machines range from August 21, 2008 to June 6, 2022. The total number of recalled devices in the US is 207 and the recall was initiated on November 25, 2022.1
On September 6, 2023, Fresenius Medical Care sent an Urgent Medical Device Correction letter to affected customers. This letter instructed customers to contact the company if they had a hemodialysis machine containing chlorinated peroxide cured silicone tubing and may not have been used or may have been in use for less than 36 days. The specific concern is related to potential for exposure to non-dioxin-like polychlorinated biphenyl acids from the tubing. For those with a new machine purchased after October 2022, no action is warranted. For those who require an update to their machine, Fresenius Medical is providing updates free of charge.1,2
The FDA highlighted the following product codes and model numbers as part of the recall:1
According to the FDA, those using affected machines could be at increased risk of serious adverse health consequences months to years after exposure. At the time of writing, there were no reports of death as a result of the potential exposure.1